Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-16-137125
Filing Date
2016-08-04
Accepted
2016-08-04 18:43:55
Documents
2
Period of Report
2016-08-04

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 3267
2 EX-24 ex-24.htm EX-24 7790
  Complete submission text file 0001104659-16-137125.txt   12421
Mailing Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167
Business Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167 248-980-6538
Gemphire Therapeutics Inc. (Issuer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 43334 SEVEN MILE ROAD SUITE 1000 NORTHVILLE MI 48167
Business Address
Lowenschuss David (Reporting) CIK: 0001674050 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37809 | Film No.: 161808738